UnknownPhase 1NCT05952596

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

Studying Diphtheria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
LG Chem
Principal Investigator
Nam Joong Kim
Seoul National University College of Medicine
Intervention
DTaP-HepB-IPV-Hib vaccine(biological)
Enrollment
42 enrolled
Eligibility
19-55 years · All sexes
Timeline
20232024

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05952596 on ClinicalTrials.gov

Other trials for Diphtheria

Additional recruiting or active studies for the same condition.

See all trials for Diphtheria

← Back to all trials